Skip to main content

Table 2 Short-term and long-term comparison of quantitative anti-HBs between 0–1–2-months and 0–1–6-months vaccination schedules

From: Two-year immune effect differences between the 0–1–2-month and 0–1–6-month HBV vaccination schedule in adults

Variables

0–1–6-months vaccination (n = 231)

0–1–2-months vaccination (n = 390)

p value

Mean ± SD

Mean ± SD

Anti-HBs1 (mIU/ml)

392.38 ± 391.96

342.12 ± 378.42

0.062

Anti-HBs2 (mIU/ml)

155.65 ± 271.73

198.37 ± 286.44

0.048

  1. Anti-HBs1, hepatitis B antibody at 2 months after three vaccination injections; Anti-HBs2, hepatitis B antibody at 2 years after three vaccination injections
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us